Stryker Corp. (SYK) News

Stryker Corp. (SYK): $233.28

0.23 (+0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter SYK News Items

SYK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SYK News Highlights

  • For SYK, its 30 day story count is now at 26.
  • Over the past 24 days, the trend for SYK's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
  • GOLD, WOLF and AG are the most mentioned tickers in articles about SYK.

Latest SYK News From Around the Web

Below are the latest news stories about Stryker Corp that investors may wish to consider to help them evaluate SYK as an investment opportunity.

Vocera Communications, Inc. Announces Fundamental Change and Make-Whole Fundamental Change With Respect to its 1.50% Convertible Senior Notes due 2023 and 0.50% Convertible Senior Notes due 2026

SAN JOSE, Calif., February 25, 2022--Vocera Communications, Inc., announces fundamental change and make-whole fundamental change with respect to its Convertible Senior Notes.

Yahoo | February 25, 2022

Stryker completes acquisition of Vocera Communications

Kalamazoo, MI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Vocera Communications, Inc. (NYSE: VCRA), a leader in digital care coordination and communication. “This acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We welcome the Vocera team to Stryker and look forward to working together

Yahoo | February 23, 2022

Those who invested in Stryker (NYSE:SYK) five years ago are up 107%

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is...

Yahoo | February 18, 2022

Stryker to participate in Cowen 42nd Annual Health Care Conference

Kalamazoo, Michigan, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Cowen 42 nd Annual Health Care Conference on Monday, March 7, 2022.

GlobeNewswire | February 15, 2022

BAX vs. SYK: Which Stock Should Value Investors Buy Now?

BAX vs. SYK: Which Stock Is the Better Value Option?

Yahoo | February 15, 2022

Worldwide Research on Regenerative Medicines Market Growth Prospects: 2022, Product Application, Current Trends, and Report Forecast to 2028 | Stryker Corporation, Zimmer Biomet Holdings

The research reports on "Regenerative Medicines Market" report give a detailed overview of the factors affecting the global scope of business. Information in the global Keyword market report provides forecast data for future market growth in global demand and supply.

OpenPR | February 11, 2022

Vocera (VCRA) Beats Q4 Earnings Estimates on Top-Line Growth

Higher revenues, software strength, and broad-based growth ably supported by dynamic business fundamentals enable Vocera (VCRA) to beat fourth-quarter 2021 earnings estimates.

Yahoo | February 11, 2022

Inflation Is No Match for This Stock

One such stock is medical devices specialist Stryker (NYSE: SYK). Stryker is one of the largest medical devices companies in the world by market cap, and it is one of the leaders in several of its business areas. Many of Stryker's products are crucial to various critical medical procedures, but the company's business was harmed by the COVID-19 pandemic -- just like that of other medical devices giants.

Yahoo | February 9, 2022

Ureteroscope Market Anticipated to Witness a Significant CAGR of 5.47% by 2026, Estimates DelveInsight

Las Vegas, USA, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Ureteroscope Market Anticipated to Witness a Significant CAGR of 5.47% by 2026, Estimates DelveInsight The growing demand for Ureteroscope Market is primarily attributed to the growing prevalence of urolithiasis or nephrolithiasis accompanied by the rising burden of obesity which is a risk factor for the development of kidney stones, and the entrance of key pharma players such as Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ in the Ureteroscope Market DelveInsight''s Ureteroscope Market Insights and Forecast report provides the current and forecast Ureteroscope, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors...

Benzinga | February 8, 2022

Hamilton Point Investment Advisors, LLC Buys Paychex Inc, Leggett & Platt Inc, Southside ...

Chapel Hill, NC, based Investment company Hamilton Point Investment Advisors, LLC (Current Portfolio) buys Paychex Inc, Leggett & Platt Inc, Southside Bancshares Inc, Truist Financial Corp, Pathfinder Bancorp Inc, sells Campbell Soup Co, AT&T Inc, PayPal Holdings Inc, Stryker Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Hamilton Point Investment Advisors, LLC.

Yahoo | February 7, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5243 seconds.